December 2024 - Angiotensin 2 Receptor Antagonists drug patent information, international generic entry, market access

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Lupin Ltd	VALSARTAN AND HYDROCHLOROTHIAZIDE	hydrochlorothiazide; valsartan	TABLET;ORAL	078946-001	Mar 21, 2013	AB	RX	No	No	⤷ Subscribe	⤷ Subscribe				⤷ Subscribe
Prinston Inc	VALSARTAN AND HYDROCHLOROTHIAZIDE	hydrochlorothiazide; valsartan	TABLET;ORAL	206083-004	Feb 8, 2016	AB	RX	No	No	⤷ Subscribe	⤷ Subscribe				⤷ Subscribe
Mylan Pharms Inc	VALSARTAN AND HYDROCHLOROTHIAZIDE	hydrochlorothiazide; valsartan	TABLET;ORAL	078020-005	Sep 21, 2012	AB	RX	No	No	⤷ Subscribe	⤷ Subscribe				⤷ Subscribe
Zydus Lifesciences	VALSARTAN AND HYDROCHLOROTHIAZIDE	hydrochlorothiazide; valsartan	TABLET;ORAL	203000-004	Mar 15, 2019		DISCN	No	No	⤷ Subscribe	⤷ Subscribe				⤷ Subscribe
Watson Labs Teva	VALSARTAN AND HYDROCHLOROTHIAZIDE	hydrochlorothiazide; valsartan	TABLET;ORAL	091519-004	Mar 21, 2013		DISCN	No	No	⤷ Subscribe	⤷ Subscribe				⤷ Subscribe
Aurobindo Pharma Ltd	VALSARTAN AND HYDROCHLOROTHIAZIDE	hydrochlorothiazide; valsartan	TABLET;ORAL	202519-005	Mar 21, 2013	AB	RX	No	No	⤷ Subscribe	⤷ Subscribe				⤷ Subscribe
Lupin Ltd	VALSARTAN AND HYDROCHLOROTHIAZIDE	hydrochlorothiazide; valsartan	TABLET;ORAL	078946-005	Mar 21, 2013	AB	RX	No	No	⤷ Subscribe	⤷ Subscribe				⤷ Subscribe
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration